Aceragen Inc (ACGN) Return on Equity ROE from the first quarter 2023 to first quarter 2022 and annually, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aceragen Inc   (NASDAQ: ACGN)

Aceragen Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Aceragen Inc in the first quarter 2023?
Aceragen Inc recorded a cumulative net loss of $-41 million during 12 months ending in the first quarter 2023, resulting in a negative return on equity (ROE) of -215.27%.

Within the Biotechnology & Pharmaceuticals industry 127 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2022 from 3840 to 4023.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Equity Change -12.75 % -59.85 % -37.09 % -43.99 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -41 -23 -12 -15 -17
Return On Equity (TTM) -215.27 % -117.43 % -48.24 % -53.32 % -53.46 %
ACGN's Total Ranking # 4023 # 3840 # 0 # 0 # 0
Equity (TTM) in Millions 23 12 21 21 26
Seq. Equity Change 90.66 % -43.06 % -1.72 % -18.23 % -12.26 %
Seq. Net Income Change - - - - -

Back to ACGN Management Effectiveness >> ACGN's 5 Years Annual ROE >> Compare ACGN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 128
Sector # 818
Overall # 4023

Return On Equity Statistics
High Average Low
765.98 %
-96.13 %
-2308.89 %
(Jun 30 2021)   (Jun 30 2020)





ACGN Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 12 29 -91 -11 64
Y / Y Equity Change -59.85 % - - - -40.58 %
Net Income in Millions -23 97 -113 -57 -60
Y / Y Net Income Change - - - - -
Return On Equity -197.53 % 329.14 % - - -93.57 %

Back to ACGN Management Effectiveness >> ACGN's 5 Years Annual ROE >> Compare ACGN ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ACGN's' Return on Equity at Yahoo Finance
ACGN's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ACGN's Competitors
Subscribers only: Roe for Aceragen Inc 's Suppliers
Subscribers only: Return On Equity for ACGN's Customers




Companies with similar Return On Equity at Mar 31 2023, within Healthcare Sector ROE

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.